Artivion Operating Margin 2010-2022 | AORT

Current and historical operating margin for Artivion (AORT) over the last 10 years. The current operating profit margin for Artivion as of September 30, 2022 is -0.73%.
Artivion Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2022-09-30 $0.31B $-0.01B -1.92%
2022-06-30 $0.31B $0.01B 4.22%
2022-03-31 $0.30B $0.01B 2.96%
2021-12-31 $0.30B $0.01B 2.68%
2021-09-30 $0.29B $0.02B 6.62%
2021-06-30 $0.28B $0.01B 2.86%
2021-03-31 $0.26B $0.01B 1.94%
2020-12-31 $0.25B $0.00B 1.19%
2020-09-30 $0.26B $0.01B 1.96%
2020-06-30 $0.26B $0.01B 2.33%
2020-03-31 $0.28B $0.02B 5.45%
2019-12-31 $0.28B $0.02B 6.50%
2019-09-30 $0.27B $0.02B 5.90%
2019-06-30 $0.27B $0.02B 5.90%
2019-03-31 $0.27B $0.01B 5.22%
2018-12-31 $0.26B $0.01B 3.44%
2018-09-30 $0.25B $0.01B 2.79%
2018-06-30 $0.23B $0.00B 1.32%
2018-03-31 $0.21B $0.00B 1.45%
2017-12-31 $0.19B $0.01B 4.74%
2017-09-30 $0.18B $0.01B 7.69%
2017-06-30 $0.18B $0.02B 9.84%
2017-03-31 $0.18B $0.02B 9.89%
2016-12-31 $0.18B $0.02B 12.22%
2016-09-30 $0.18B $0.02B 12.57%
2016-06-30 $0.17B $0.02B 11.98%
2016-03-31 $0.16B $0.02B 9.62%
2015-12-31 $0.15B $0.01B 4.08%
2015-09-30 $0.14B $0.00B 2.08%
2015-06-30 $0.14B $0.00B 2.08%
2015-03-31 $0.14B $0.01B 3.50%
2014-12-31 $0.15B $0.01B 6.21%
2014-09-30 $0.14B $0.01B 6.99%
2014-06-30 $0.14B $0.01B 8.45%
2014-03-31 $0.14B $0.01B 9.22%
2013-12-31 $0.14B $0.01B 9.93%
2013-09-30 $0.14B $0.01B 9.35%
2013-06-30 $0.14B $0.01B 8.09%
2013-03-31 $0.14B $0.01B 10.37%
2012-12-31 $0.13B $0.01B 9.92%
2012-09-30 $0.13B $0.01B 10.94%
2012-06-30 $0.13B $0.01B 10.40%
2012-03-31 $0.12B $0.01B 9.09%
2011-12-31 $0.12B $0.01B 9.24%
2011-09-30 $0.12B $0.01B 10.17%
2011-06-30 $0.12B $0.01B 7.76%
2011-03-31 $0.12B $0.01B 8.62%
2010-12-31 $0.12B $0.01B 9.48%
2010-09-30 $0.12B $0.01B 9.48%
2010-06-30 $0.12B $0.02B 12.93%
2010-03-31 $0.12B $0.01B 12.17%
2009-12-31 $0.11B $0.01B 12.50%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.566B $0.299B
Artivion Inc. is a medical device company. It focused on developing simple, elegant solutions which address cardiac and vascular surgeons. The company's group of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts and surgical sealants. Artivion Inc., formerly known as CryoLife Inc., is headquartered in suburban Atlanta, Georgia.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $230.517B 25.29
Edwards Lifesciences (EW) United States $50.772B 33.11
Alcon (ALC) Switzerland $37.369B 32.17
STERIS (STE) Ireland $21.864B 27.21
Teleflex (TFX) United States $12.124B 19.67
Fresenius Medical Care AG KGaA (FMS) Germany $11.123B 11.16
Penumbra (PEN) United States $9.913B 2372.91
Globus Medical (GMED) United States $7.950B 40.42
Glaukos (GKOS) United States $2.458B 0.00
Integer Holdings (ITGR) United States $2.435B 19.55
AVANOS MEDICAL, INC (AVNS) United States $1.469B 20.92
Nevro (NVRO) United States $1.410B 0.00
Paragon 28 (FNA) United States $1.346B 0.00